Comparison of aprepitant versus desloratadine for EGFR‐TKI‐induced pruritus: A randomized phase 2 clinical trial-Reference-Cited by-同舟云学术

Comparison of aprepitant versus desloratadine for EGFR‐TKI‐induced pruritus: A randomized phase 2 clinical trial

Published:2022-10-05 Issue:22 Volume:128 Page:3969-3976
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Zhou Ting¹^ORCID,Zhang Yaxiong¹,Ma Yuxiang²,Ma Wenjuan³,Wu Xuan⁴,Huang Lu⁵,Feng Weineng⁶,Zhou Huaqiang¹,Liu Jiaqing¹,Zhao Hongyun²,Zhang Li¹,Yang Yunpeng¹,Huang Yan¹

Affiliation:

1. Department of Medical Oncology Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangzhou Guangdong China

2. Department of Clinical Research Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangzhou Guangdong China

3. Department of Intensive Care Unit Sun Yat‐sen University Cancer Center State Key Laboratory of Oncology in South China Collaborative Innovation Center for Cancer Medicine Guangzhou Guangdong China

4. Department of Medical Oncology Peking University Shenzhen Hospital Shenzhen Guangdong China

5. Department of Medical Oncology Central Hospital of Guangdong Nongken Zhanjiang Cancer Hospital Zhanjiang China

6. Department of Medical Oncology The First People's Hospital of Foshan Foshan Guangdong China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.34474

Reference32 articles.

1. Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

2. Osimertinib in UntreatedEGFR-Mutated Advanced Non–Small-Cell Lung Cancer

3. Skin problems and EGFR-tyrosine kinase inhibitor

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus of the Taiwanese dermatological association and Taiwan Lung Cancer Society on the prevention and management of tyrosine kinase inhibitor-related skin toxicities in patients with non-small cell lung cancer: An updated version incorporating Taiwanese treatment experience;Journal of the Formosan Medical Association;2024-08

2. Pruritus in the Elderly: Differential Diagnosis and Management;Current Geriatrics Reports;2024-05-23

3. A Systematic Review of Literatures: To Identify Non-Cancer Drugs Repurposed for Lung Cancer;2023-12-04

4. Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma;Molecular Oncology;2023-07-14

5. Postoperative nausea and vomiting: is the big little problem becoming a smaller little problem?;British Journal of Anaesthesia;2023-07